Designing new generation of potent inhibitors against membrane-type matrix metalloproteinase-2: a computational effort against multiple myeloma

References

• Abraham, M. J., & Gready, J. E. (2011). Optimization of parameters for molecular dynamics simulation using smooth particle‐mesh Ewald in GROMACS 4.5. Journal of Computational Chemistry, 32, 2031–2040. doi:10.1002/jcc.21773
   PubMed Web of Science ®Google Scholar
• Abramyan, T. M., Snyder, J. A., Thyparambil, A. A., Stuart, S. J., & Latour, R. A. (2016). Cluster analysis of molecular simulation trajectories for systems where both conformation and orientation of the sampled states are important. Journal of Computational Chemistry, 37, 1973–1982. doi:10.1002/jcc.24416
   PubMed Web of Science ®Google Scholar
• Aldeghi, M., Heifetz, A., Bodkin, M. J., Knapp, S., & Biggin, P. C. (2016). Accurate calculation of the absolute free energy of binding for drug molecules. Chemical Science, 7(1), 207–218. doi:10.1039/c5sc02678d
   PubMed Web of Science ®Google Scholar
• Banavath, H. N., Sharma, O. P., Kumar, M. S., & Baskaran, R. (2015). Identification of novel tyrosine kinase inhibitors for drug resistant T315I mutant BCR-ABL: A virtual screening and molecular dynamics simulations study. Scientific Reports, 4(1), 6948. doi:10.1038/srep06948
   Google Scholar
• Bianch, G., Kumar, S., Ghobrial, I., & Roccaro, A. (2012). Cell trafficking in multiple myeloma. Open Journal of Hematology, 3, 1–17.
   Google Scholar
• Braga, E. J., Corpe, B. T., Marinho, M. M., & Marinho, E. S. (2016). Molecular electrostatic potential surface, HOMO–LUMO, and computational analysis of synthetic drug Rilpivirine. International Journal of Scientific Research & Engineering, 7, 315–319.
   Google Scholar
• Brun, L., Isom, D. G., Velu, P., García-Moreno, B., & Royer, C. A. (2006). Hydration of the folding transition state ensemble of a protein. Biochemistry, 45, 3473–3480. doi:10.1021/bi052638z
   PubMed Web of Science ®Google Scholar
• Cathcart, J., Pulkoski-Gross, A., & Cao, J. (2015). Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas. Genes & Diseases, 2(1), 26–34. doi:10.1016/j.gendis.2014.12.002
   PubMed Web of Science ®Google Scholar
• Colovos, C., & Yeates, T. O. (1993). Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Science, 2, 1511–1519. doi:10.1002/pro.5560020916
   PubMed Web of Science ®Google Scholar
• Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002). Matrix metalloproteinase inhibitors and cancer: Trials and tribulations. Science, 295, 2387–2392. doi:10.1126/science.1067100
   PubMed Web of Science ®Google Scholar
• Dubey, K. D., & Ojha, R. P. (2011). Binding free energy calculation with QM/MM hybrid methods for Abl-Kinase inhibitor. Journal of Biological Physics, 37(1), 69–78. doi:10.1007/s10867-010-9199-z
   PubMed Web of Science ®Google Scholar
• Dubin, A., Lattanzio, B., & Gatti, L. (2017). The spectrum of cardiovascular effects of dobutamine-from healthy subjects to septic shock patients. Revista Brasileira de Terapia Intensiva, 29, 490–498. doi:10.5935/0103-507X.20170068
   PubMedGoogle Scholar
• Eisenberg, D., Lüthy, R., & Bowie, J. U. (1997). [20] VERIFY3D: Assessment of protein models with three-dimensional profiles. Methods in Enzymology, 277, 396–404.
   PubMed Web of Science ®Google Scholar
• English, W. R., Holtz, B., Vogt, G., Knauper, V., & Murphy, G. (2001). Characterization of the role of the “MT-loop”: An eight-amino acid insertion specific to progelatinase A (MMP2) activating membrane-type matrix metalloproteinases. Journal of Biological Chemistry, 276, 42018–42026. doi:10.1074/jbc.M107783200
   PubMed Web of Science ®Google Scholar
• Fernandez-Catalan, C., Bode, W., Huber, R., Turk, D., Calvete, J. J., Lichte, A., … Maskos, K. (1998). Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. The EMBO Journal, 17, 5238–5248. doi:10.1093/emboj/17.17.5238
   PubMed Web of Science ®Google Scholar
• Fields, G. B. (2015). New strategies for targeting matrix metalloproteinases. Matrix Biology, 44–46, 239–246. doi:10.1016/j.matbio.2015.01.002
   PubMed Web of Science ®Google Scholar
• Godói, I. P., Lima, W. G., Comar Junior, M., Alves, R. J., Ferreira, J. M. S., Kong, D.-X., & Taranto, A. G. (2017). Docking and QM/MM studies of NS2B-NS3pro inhibitors: A molecular target against the dengue virus. Journal of the Brazilian Chemical Society, 28, 895–906. doi:10.21577/0103-5053.20160242
   Web of Science ®Google Scholar
• Grasso, G., Deriu, M. A., Tuszynski, J. A., Gallo, D., Morbiducci, U., & Danani, A. (2016). Conformational fluctuations of the AXH monomer of Ataxin‐1. Proteins: Structure, Function, and Bioinformatics, 84(1), 52–59. doi:10.1002/prot.24954
   PubMed Web of Science ®Google Scholar
• Hess, B. (2008). P-LINCS: A parallel linear constraint solver for molecular simulation. Journal of Chemical Theory and Computation, 4(1), 116–122. doi:10.1021/ct700200b
   PubMed Web of Science ®Google Scholar
• Hou, D.-D., Zhang, W., Gao, Y.-L., Sun, Y-Z., Wang, H.-X., Qi, R.-Q., … Gao, X.-H. (2019). Anti-inflammatory effects of quercetin in a mouse model of MC903-induced atopic dermatitis. International Immunopharmacology, 74, 105676. doi:10.1016/j.intimp.2019.105676
   PubMed Web of Science ®Google Scholar
• Itoh, Y. (2015). Membrane-type matrix metalloproteinases: Their functions and regulations. Matrix Biology, 44–46, 207–223. doi:10.1016/j.matbio.2015.03.004
   PubMed Web of Science ®Google Scholar
• Jain, A. K., Murty, M. N., & Flynn, P. J. (1999). Data clustering: A review. ACM Computing Surveys, 31, 264–323. doi:10.1145/331499.331504
   Web of Science ®Google Scholar
• John, A., & Tuszynski, G. (2001). The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathology & Oncology Research, 7(1), 14–23. doi:10.1007/BF03032599
   PubMedGoogle Scholar
• Kim, R., & Skolnick, J. (2008). Assessment of programs for ligand binding affinity prediction. Journal of Computational Chemistry, 29, 1316–1331. doi:10.1002/jcc.20893
   PubMed Web of Science ®Google Scholar
• Kyle, R. A., & Rajkumar, S. V. (2004). Multiple myeloma. The New England Journal of Medicine, 351, 1860–1873. doi:10.1056/NEJMra041875
   PubMed Web of Science ®Google Scholar
• Laskowski, R., MacArthur, M., & Thornton, J. (2012). PROCHECK: Validation of protein-structure coordinates. In C. P. Brock (Eds.), International Tables for Crystallography. doi:10.1107/97809553602060000882
   Google Scholar
• Morrison, C. J., & Overall, C. M. (2006). TIMP independence of matrix metalloproteinase (MMP)-2 activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-MMP catalytic and hemopexin C domains. The Journal of Biological Chemistry, 281, 26528–26539. doi:10.1074/jbc.M603331200
   PubMed Web of Science ®Google Scholar
• Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52, 7182–7190. doi:10.1063/1.328693
   Web of Science ®Google Scholar
• Saragusti, A. C., Ortega, M. G., Cabrera, J. L., Estrin, D. A., Marti, M. A., & Chiabrando, G. A. (2010). Inhibitory effect of quercetin on matrix metalloproteinase 9 activity molecular mechanism and structure–activity relationship of the flavonoid–enzyme interaction. European Journal of Pharmacology, 644(1–3), 138–145. doi:10.1016/j.ejphar.2010.07.001
   PubMed Web of Science ®Google Scholar
• Singh, A., Kaushik, R., Mishra, A., Shanker, A., & Jayaram, B. (2016). ProTSAV: A protein tertiary structure analysis and validation server. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1864(1), 11–19. doi:10.1016/j.bbapap.2015.10.004
   PubMed Web of Science ®Google Scholar
• Singh, T., Adekoya, O. A., & Jayaram, B. (2015). Understanding the binding of inhibitors of matrix metalloproteinases by molecular docking, quantum mechanical calculations, molecular dynamics simulations, and a MMGBSA/MMBappl study. Molecular Biosystems, 11, 1041–1051. doi:10.1039/C5MB00003C
   PubMed Web of Science ®Google Scholar
• Tryon, R. C. (1939). Cluster analysis: Correlation profile and orthometric (factor) analysis for the isolation of unities in mind and personality. Ann Arbor: Edwards Brother, Incorporated.
   Google Scholar
• Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. (2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26, 1701–1718. doi:10.1002/jcc.20291
   PubMed Web of Science ®Google Scholar
• Vihinen, P., & Kahari, V. M. (2002). Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets. International Journal of Cancer, 99, 157–166. doi:10.1002/ijc.10329
   PubMed Web of Science ®Google Scholar
• Vijayababu, M., Arunkumar, A., Kanagaraj, P., Venkataraman, P., Krishnamoorthy, G., & Arunakaran, J. (2006). Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3). Molecular and Cellular Biochemistry, 287(1–2), 109–116. doi:10.1007/s11010-005-9085-3
   PubMed Web of Science ®Google Scholar
• Webb, B., & Sali, A. (2014). Comparative protein structure modeling using MODELLER. Current Protocols in Bioinformatics, 47(1), 5.6.1–5.6.32. doi:10.1002/0471250953.bi0506s47
   Google Scholar
• Woskowicz, A. M., Weaver, S. A., Shitomi, Y., Ito, N., & Itoh, Y. (2013). MT-LOOP-dependent localization of membrane type I matrix metalloproteinase (MT1-MMP) to the cell adhesion complexes promotes cancer cell invasion. Journal of Biological Chemistry, 288, 35126–35137. doi:10.1074/jbc.M113.496067
   PubMed Web of Science ®Google Scholar
• Xie, B., Xu, Z., Yang, G., Chen, G., Li, B., Hu, L., … Gao, L. (2016). Antitumor effect of dobutamine on multiple myeloma via mitogen-activated protein kinase pathway in vitro. Acta Biochimica et Biophysica Sinica, 48(12), 1135-1137. doi:10.1093/abbs/gmw110.
   Web of Science ®Google Scholar
• Xu, R., & Wunsch, D. C. (2005). Survey of clustering algorithms.
   Google Scholar
• Yin, J., Dong, Q., Zheng, M., Xu, X., Zou, G., Ma, G., & Li, K. (2016). Antitumor activity of dobutamine on human osteosarcoma cells. Oncology Letters, 11, 3676–3680. doi:10.3892/ol.2016.4479
   PubMed Web of Science ®Google Scholar
• Zhang, D., & Lazim, R. (2017). Application of conventional molecular dynamics simulation in evaluating the stability of apomyoglobin in urea solution. Scientific Reports, 7(1), 44651. doi:10.1038/srep44651
   PubMed Web of Science ®Google Scholar
• Zhao, H., & Caflisch, A. (2015). Molecular dynamics in drug design. European Journal of Medicinal Chemistry, 91, 4–14. doi:10.1016/j.ejmech.2014.08.004
   PubMed Web of Science ®Google Scholar
• Zheng, H.-X., Wu, L.-N., Xiao, H., Du, Q., & Liang, J.-F. (2014). Inhibitory effects of dobutamine on human gastric adenocarcinoma. World Journal of Gastroenterology, 20, 17092. doi:10.3748/wjg.v20.i45.17092
   PubMed Web of Science ®Google Scholar
• Zucker, S., Cao, J., & Chen, W. T. (2000). Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene, 19, 6642–6650. doi:10.1038/sj.onc.1204097
   PubMed Web of Science ®Google Scholar